Top

American Journal of Clinical Dermatology

Published in:

01-02-2012 | Original Research Article

Atopic Dermatitis and Risk of Skin Cancer

A Danish Nationwide Cohort Study (1977–2006)

Authors: Dr Annette O. Jensen, Claus Svaerke, Dora Körmendiné Farkas, Anne B. Olesen, Knud Kragballe, Henrik T. Sørensen

Published in: American Journal of Clinical Dermatology | Issue 1/2012

Abstract

Background: Recent data suggest a reduced risk of malignant melanoma (MM) among atopic dermatitis (AD) patients, but an increased risk of other skin cancers (including basal cell carcinoma [BCC] and squamous cell carcinoma [SCC]).

Objective: We examined the association between AD and skin cancers in a large cohort study in Denmark from 1977 through 2006.

Methods: Our cohort consisted of 31 330 AD patients recorded in the Danish National Patient Registry, including AD patients admitted to hospitals and specialized outpatient clinics. Linkage to the Danish Cancer Registry allowed ascertainment of skin cancers. We calculated standardized incidence ratios (SIRs) and associated 95% confidence intervals (CIs) by comparing the incidence rate of skin cancers among AD patients with that among the general Danish population.

Results: The overall observed number of MM cases among AD patients was 12, with 21 expected, yielding a SIR of 0.59 (95% CI 0.30, 1.02), with the most pronounced protective effect among AD patients with more than 5 years of follow-up (SIR = 0.46; 95% CI 0.19, 0.95). The corresponding SIRs for BCC and SCC were increased among AD patients (1.41 [95% CI 1.07, 1.83] and 2.48 [95% CI 1.00, 5.11], respectively).

Conclusions: Our findings support an inverse association between AD and MM, but an increased risk of BCC and SCC among AD patients.

Available only for authorised users

Keil T, Kulig M, Simpson A, et al. European birth cohort studies on asthma and atopic diseases: I. Comparison of study designs: a GALEN initiative. Allergy 2006 Feb; 61 (2): 221–8

Leiter U, Garbe C. Epidemiology of melanoma and nonmelanoma skin cancer: the role of sunlight. Adv Exp Med Biol 2008; 624: 89–103PubMedCrossRef

Synnerstad I, Fredrikson M, Ternesten-Bratel A, et al. Low risk of melanoma in patients with atopic dermatitis. J Eur Acad Dermatol Venereol 2008 Dec; 22 (12): 1423–8

Hagstromer L, Ye W, Nyren O, et al. Incidence of cancer among patients with atopic dermatitis. Arch Dermatol 2005 Sep; 141 (9): 1123–7

Olesen AB, Engholm G, Storm HH, et al. The risk of cancer among patients previously hospitalized for atopic dermatitis. J Invest Dermatol 2005 Sep; 125 (3): 445–9

Ji J, Shu X, Li X, et al. Cancer risk in hospitalised asthma patients. Br J Cancer 2009 Mar 10; 100 (5): 829–33

Frank L. Epidemiology: when an entire country is a cohort. Science 2000 Mar 31; 287 (5462): 2398–9

Andersen TF, Madsen M, Jorgensen J, et al. The Danish National Hospital Register: a valuable source of data for modern health sciences. Dan Med Bull 1999 Jun; 46 (3): 263–8

Adami J, Gabel H, Lindelof B, et al. Cancer risk following organ transplantation: a nationwide cohort study in Sweden. Br J Cancer 2003 Oct 6; 89 (7): 1221–7

10.

Jensen AO, Olesen AB, Dethlefsen C, et al. Chronic diseases requiring hospitalization and risk of non-melanoma skin cancers: a population based study from Denmark. J Invest Dermatol 2008 Apr; 128 (4): 926–31

11.

Storm HH, Michelsen EV, Clemmensen IH, et al. The Danish Cancer Registry: history, content, quality and use. Dan Med Bull 1997 Nov; 44 (5): 535–9

12.

Breslow NE, Day NE. Statistical methods in cancer research: volume II. The design and analysis of cohort studies. IARC Sci Publ 1987; (82): 1–406

13.

Rothman KJ. Epidemiology: an introduction. New York (NY): Oxford University Press, 2002

14.

Mittelman A, Chen ZJ, Liu CC, et al. Kinetics of the immune response and regression of metastatic lesions following development of humoral anti-high molecular weight-melanoma associated antigen immunity in three patients with advanced malignant melanoma immunized with mouse antiidiotypic monoclonal antibody MK2-23. Cancer Res 1994 Jan 15; 54 (2): 415–21

15.

Mukherji B, Chakraborty NG. Immunobiology and immunotherapy of melanoma. Curr Opin Oncol 1995 Mar; 7 (2): 175–84

16.

Leung DY, Boguniewicz M, Howell MD, et al. New insights into atopic dermatitis. J Clin Invest 2004 Mar; 113 (5): 651–7

17.

Swope VB, Abdel-Malek Z, Kassem LM, et al. Interleukins 1 alpha and 6 a nd tumor necrosis factor-alpha are paracrine inhibitors of human melanocyte proliferation and melanogenesis. J Invest Dermatol 1991 Feb; 96 (2): 180–5

18.

Krasagakis K, Garbe C, Eberle J, et al. Tumour necrosis factors and several interleukins inhibit the growth and modulate the antigen expression of normal human melanocytes in vitro. Arch Dermatol Res 1995; 287 (3-4): 259–65PubMedCrossRef

19.

Broberg A, Augustsson A. Atopic dermatitis and melanocytic naevi. Br J Dermatol 2000 Feb; 142 (2): 306–9

20.

Swerdlow AJ, English J, MacKie RM, et al. Benign naevi associated with high risk of melanoma [letter]. Lancet 1984 Jul 21; 2 (8395): 168

21.

Holly EA, Kelly JW, Shpall SN, et al. Number of melanocytic nevi as a major risk factor for malignant melanoma. J Am Acad Dermatol 1987 Sep; 17 (3): 459–68

22.

Holman CD, Armstrong BK. Pigmentary traits, ethnic origin, benign nevi, and family history as risk factors for cutaneous malignant melanoma. J Natl Cancer Inst 1984 Feb; 72 (2): 257–66

23.

Lea CS, Scotto JA, Buffler PA, et al. Ambient UVB and melanoma risk in the United States: a case-control analysis. Ann Epidemiol 2007 Jun; 17 (6): 447–53

24.

Sorensen HT, Mellemkjaer L, Nielsen GL, et al. Skin cancers and non- Hodgkin lymphoma among users of systemic glucocorticoids: a populationbased cohort study. J Natl Cancer Inst 2004 May 5; 96 (9): 709–11

25.

Jensen AO, Thomsen HF, Engebjerg MC, et al. Use of oral glucocorticoids and risk of skin cancer and non-Hodgkins lymphoma: a population-based case-control study. Br J Cancer 2009 Jan 13; 100 (1): 200–5

26.

Madan V, Lear JT, Szeimies RM. Non-melanoma skin cancer. Lancet Feb 20; 375 (9715): 673–85

27.

Stern RS, Liebman EJ, Vakeva L. Oral psoralen and ultraviolet-Alight (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer: PUVA Follow-up Study. J Natl Cancer Inst 1998 Sep 2; 90 (17): 1278–84

28.

Rosso S, Zanetti R, Martinez C, et al. The multicentre south European study Helios: II. Different sun exposure patterns in the aetiology of basal cell and squamous cell carcinomas of the skin. Br J Cancer 1996 Jun; 73 (11): 1447–54

29.

Ming ME, Levy R, Hoffstad O, et al. The lack of a relationship between atopic dermatitis and nonmelanoma skin cancers. J Am Acad Dermatol 2004 Mar; 50 (3): 357–62

30.

Olesen AB, Ellingsen AR, Olesen H, et al. Atopic dermatitis and birth factors: historical follow up by record linkage. BMJ 1997 Apr 5; 314 (7086): 1003–8

31.

Mills CM, Srivastava ED, Harvey IM, et al. Cigarette smoking is not a risk factor in atopic dermatitis. Int J Dermatol 1994 Jan; 33 (1): 33–4

Title: Atopic Dermatitis and Risk of Skin Cancer
A Danish Nationwide Cohort Study (1977–2006)
Authors: Dr Annette O. Jensen
Claus Svaerke
Dora Körmendiné Farkas
Anne B. Olesen
Knud Kragballe
Henrik T. Sørensen
Publication date: 01-02-2012
Publisher: Springer International Publishing
Published in: American Journal of Clinical Dermatology / Issue 1/2012
Print ISSN: 1175-0561
Electronic ISSN: 1179-1888
DOI: https://doi.org/10.2165/11593280-000000000-00000

ACC 2024 Congress

Springer Medicine

Atopic Dermatitis and Risk of Skin Cancer

A Danish Nationwide Cohort Study (1977–2006)

Abstract

ACC 2024 Congress

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2012

KIT and BRAF Mutational Status in a Patient with a Synchronous Lentigo Maligna Melanoma and a Gastrointestinal Stromal Tumor

Eruptive Vellus Hair Cysts

Incidence of Toxic Epidermal Necrolysis and Stevens-Johnson Syndrome in an HIV Cohort

Long-Term Treatment of Severe SAPHO Syndrome with Adalimumab

Body Piercing

Erythroid Disturbances Before and After Treatment of Portuguese Psoriasis Vulgaris Patients